{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:37:59Z","timestamp":1762101479922},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.058","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T06:15:22Z","timestamp":1381990522000},"page":"35-42","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fenofibrate A peroxisome proliferator activated receptor-\u03b1 agonist treatment ameliorates Concanavalin A-induced hepatitis in rats"],"prefix":"10.1016","volume":"721","author":[{"given":"Doaa I.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.M.","family":"Elmelegy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna F.A.","family":"El-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala S.","family":"Abdel kawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer A. Abd","family":"El-Samad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omnyah A.","family":"El-Kharashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.058_bib1","series-title":"Theory and Practice of Histological Techniques","volume":"121","author":"Bancroft","year":"2008"},{"issue":"48","key":"10.1016\/j.ejphar.2013.09.058_bib2","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.3748\/wjg.v11.i48.7591","article-title":"Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor \u03b1 and carnitine palmitoyl acyl-CoA transferase 1A","volume":"11","author":"Cheng","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2013.09.058_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-230X-7-44","article-title":"Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study","volume":"7","author":"Cindoruk","year":"2007","journal-title":"BMC Gastroenterol."},{"issue":"5\u20136","key":"10.1016\/j.ejphar.2013.09.058_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1163\/156856005774382724","article-title":"The peroxisome proliferator-activated receptor \u03b1 activator, Wy14, 643, is anti-inflammatory in vivo","volume":"12","author":"Colville-Nash","year":"2005","journal-title":"Inflammopharmacology"},{"issue":"19\u201320","key":"10.1016\/j.ejphar.2013.09.058_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.lfs.2008.01.022","article-title":"The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice","volume":"82","author":"Cong","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.09.058_bib6","first-page":"5","article-title":"Peroxisome proliferator-activated receptors in HCV-related infection","author":"Dharancy","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejphar.2013.09.058_bib7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2013.09.058_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.058_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis-from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.058_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/019262339602400105","article-title":"Importance of and approaches to quantification of hepatocyte apoptosis","volume":"24","author":"Goldsworthy","year":"1996","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.058_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2036.2006.02729.x","article-title":"Peroxisome proliferator-activated receptor-\u03b1 and -\u03b3 mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection","volume":"23","author":"Gottardi","year":"2006","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.09.058_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellimm.2008.02.003","article-title":"Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis","volume":"251","author":"Hatano","year":"2008","journal-title":"Cell Immunol."},{"issue":"2","key":"10.1016\/j.ejphar.2013.09.058_bib14","first-page":"70","article-title":"Serum markers of liver fibrogenesis, and liver histology findings in patients with chronic liver diseases","volume":"103","author":"Holoman","year":"2002","journal-title":"Bratisl. Lek. Listy."},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.058_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2131\/jts.34.377","article-title":"Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats","volume":"34","author":"Kobayashi","year":"2009","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2013.09.058_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00441-002-0670-4","article-title":"Apoptosis of T cells in the hepatic fibrotic tissue of the rat: a possible inducing role of hepatic myofibroblast-like cells","volume":"311","author":"Kobayashi","year":"2003","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.ejphar.2013.09.058_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1478-3231.2008.01841.x","article-title":"Endogenous alpha-calcitonin gene-related peptid mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin a","volume":"29","author":"Kamiyoshi","year":"2009","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.ejphar.2013.09.058_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1172\/JCI119578","article-title":"Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites","volume":"100","author":"L\u00f3pez-Talavera","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.058_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2567.2009.03149.x","article-title":"Immunological aspects and therapeutic significance of an autoantibody against histone H1 in a rat model of concanavalin A-induced hepatitis","volume":"129","author":"Nakano","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2013.09.058_bib21","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/carcin\/21.4.823","article-title":"Peroxisome proliferator-activated receptor \u03b1 is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis","volume":"21","author":"Peters","year":"2000","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.058_bib22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coph.2006.03.012","article-title":"PPARs and other nuclear receptors in inflammation","volume":"6","author":"Rizzo","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2013.09.058_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2011.12.008","article-title":"PPAR\u03b1 activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats","volume":"56","author":"Rodr\u00edguez-Vilarrupla","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.058_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1109\/58.996561","article-title":"Shear elasticity probe for soft tissues with 1-D transient elastography","volume":"49","author":"Sandrin","year":"2002","journal-title":"IEEE Trans. Ultrason. Ferroelectr. Freq. Control"},{"issue":"5","key":"10.1016\/j.ejphar.2013.09.058_bib25","first-page":"1233","article-title":"Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers","volume":"138","author":"Schmitt-Gr\u00e4ff","year":"1991","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.058_bib26","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2013.09.058_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10620-009-0732-5","article-title":"Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers","volume":"55","author":"Shirin","year":"2010","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.058_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1440-1746.2006.04819.x","article-title":"PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes","volume":"23","author":"Seo","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ejphar.2013.09.058_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","article-title":"PPAR\u03b1 ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats","volume":"324","author":"Toyama","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2013.09.058_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20071570","article-title":"Liver fibrosis","volume":"411","author":"Wallace","year":"2008","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ejphar.2013.09.058_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2010.03.005","article-title":"Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage","volume":"323","author":"Zhou","year":"2010","journal-title":"Mol. Cell. Endocrinol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991300722X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991300722X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T18:46:18Z","timestamp":1716057978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991300722X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S001429991300722X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.058","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fenofibrate A peroxisome proliferator activated receptor-\u03b1 agonist treatment ameliorates Concanavalin A-induced hepatitis in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}